Latest & greatest articles for Adenomyosis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on Adenomyosis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on Adenomyosis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for Adenomyosis

41. Cardiac arrest due to massive hemorrhage from uterine adenomyosis with leiomyoma successfully treated with damage control resuscitation Full Text available with Trip Pro

Cardiac arrest due to massive hemorrhage from uterine adenomyosis with leiomyoma successfully treated with damage control resuscitation A 57-year-old woman was transferred to our emergency department by ambulance with cardiopulmonary arrest caused by massive genital bleeding. Cardiopulmonary resuscitation, including massive transfusion, was carried out and the return of spontaneous circulation was achieved. A giant uterine tumor was considered the source of the bleeding. Although hysterectomy

2016 Acute medicine & surgery

42. Pregnancy outcomes in women with endometriosis: a national record linkage study (Abstract)

Pregnancy outcomes in women with endometriosis: a national record linkage study To determine pregnancy outcomes in women with endometriosis.A national population based cohort study using record linkage.Scotland.A cohort of 14 655 women followed up over a 30-year period (1981-2010).In a nationwide Scottish study, we compared pregnancy outcomes in 5375 women with surgically confirmed endometriosis with outcomes in 8710 women without endometriosis who were pregnant during the same time period (...) , socio-economic status and year of delivery, women with endometriosis when compared to women without endometriosis, had a significantly higher risk of early pregnancy complications with adjusted OR (95% CI) of 1.76 (1.44, 2.15) and 2.70 (1.09, 6.72) for miscarriage and ectopic pregnancy, respectively. A previous diagnosis of endometriosis was associated with a significantly increased risk of [adjusted OR (95% CI)] placenta praevia [2.24 (1.52, 3.31)], unexplained antepartum haemorrhage [1.67 (1.39

2016 EvidenceUpdates

43. Endometriosis: When should I suspect endometriosis?

Endometriosis: When should I suspect endometriosis? When to suspect endometriosis | Diagnosis | Endometriosis | CKS | NICE Search CKS… Menu When to suspect endometriosis Endometriosis: When should I suspect endometriosis? Last revised in February 2020 When should I suspect endometriosis? Suspect endometriosis in women (including young women aged 17 years and younger) presenting with 1 or more of the following symptoms or signs: Chronic pelvic pain (defined as a minimum of 6 months of cyclical (...) or continuous pain). Period-related pain (dysmenorrhoea) affecting daily activities and quality of life. Deep pain during or after sexual intercourse. Period-related or cyclical gastrointestinal symptoms, in particular painful bowel movements. Period-related or cyclical urinary symptoms, in particular blood in the urine or pain passing urine. Infertility in association with 1 or more of the above. If endometriosis is suspected: Take a detailed history. Ask questions about the symptoms and have a full

2016 NICE Clinical Knowledge Summaries

44. Endometriosis: What else might it be?

Endometriosis: What else might it be? Differential diagnosis | Diagnosis | Endometriosis | CKS | NICE Search CKS… Menu Differential diagnosis Endometriosis: What else might it be? Last revised in February 2020 What else might it be? Differential diagnoses of endometriosis include: Uterine conditions, such as: Adenomyosis or uterine fibroids — typically causes lower abdominal pain and heavy menstrual bleeding, and an enlarged uterus may be identified on pelvic examination. See the CKS topic (...) . Urological conditions, such as: Interstitial cystitis — diffuse chronic pain and dyspareunia are common and often indistinguishable from endometriosis. Symptoms are primarily localized to the bladder, such as urinary frequency and urgency. The woman may complain of pain with a full bladder that is relieved upon voiding. Recurrent urinary tract infections (UTIs) — typical features of a UTI include dysuria, frequency, urgency, changes in urine appearance or consistency, nocturia, and suprapubic discomfort

2016 NICE Clinical Knowledge Summaries

45. Endometriosis: Scenario: Management of endometriosis

, specialist endometriosis service, or paediatric and adolescent gynaecology service (as appropriate) for investigation and consideration of , including surgery (laparoscopy). For women with confirmed endometriosis, particularly women who choose not to have surgery, ensure that they are followed up in secondary care if they have: Deep endometriosis involving the bowel, bladder or ureter or One or more endometrioma that is larger than 3 cm. Secondary care assessment and investigations Diagnosis (...) , if present, should be considered: Peritoneal endometriosis not involving the bowel, bladder, or ureter. Uncomplicated ovarian endometriomas. As an adjunct to surgery for deep endometriosis involving the bowel, bladder, or ureter, 3 months of treatment with a gonadotrophin-releasing hormone agonists should be considered before surgery. Excision rather than ablation should be considered to treat endometriomas, taking into account the woman's desire for fertility and her ovarian reserve. Combination

2016 NICE Clinical Knowledge Summaries

46. Endometriosis

Endometriosis Endometriosis | Topics A to Z | CKS | NICE Search CKS… Menu Endometriosis Endometriosis Last revised in February 2020 Endometriosis is the presence of tissue resembling endometrial glands and stroma outside the uterine cavity Diagnosis Management Background information Endometriosis: Summary Endometriosis is characterized by the growth of endometrium-like tissue outside the uterus. Endometriotic deposits are most commonly distributed in the pelvis; on the ovaries, peritoneum (...) , uterosacral ligaments, and pouch of Douglas. Extrapelvic deposits, such as in the bowel and pleural cavity, are rare. Endometriosis is associated with menstruation. The hormonal changes in the menstrual cycle induce bleeding, chronic inflammation, and scar tissue formation. The exact cause of endometriosis is unknown. It is thought that endometriosis develops as a result of a combination of several factors, including retrograde menstruation, personal genetics, metaplasia, and environmental factors

2016 NICE Clinical Knowledge Summaries

47. The issues surrounding the pre‐operative TVS diagnosis of rectovaginal septum endometriosis Full Text available with Trip Pro

The issues surrounding the pre‐operative TVS diagnosis of rectovaginal septum endometriosis 28191201 2018 11 13 1836-6864 17 1 2014 Feb Australasian journal of ultrasound in medicine Australas J Ultrasound Med The issues surrounding the pre-operative TVS diagnosis of rectovaginal septum endometriosis. 2-3 10.1002/j.2205-0140.2014.tb00082.x Reid Shannon S University of Sydney. Condous George G Acute Gynaecology, Early Pregnancy and Advanced Endosurgery Unit Sydney Medical School University

2015 Australasian journal of ultrasound in medicine

48. Should ureteric assessment be included in the transvaginal ultrasound assessment for women with suspected endometriosis? Full Text available with Trip Pro

Should ureteric assessment be included in the transvaginal ultrasound assessment for women with suspected endometriosis? 28191234 2018 11 13 1836-6864 18 1 2015 Feb Australasian journal of ultrasound in medicine Australas J Ultrasound Med Should ureteric assessment be included in the transvaginal ultrasound assessment for women with suspected endometriosis? 2 10.1002/j.2205-0140.2015.tb00021.x Reid Shannon S Acute Gynaecology Early Pregnancy and Advanced Endosurgery Unit Sydney Medical School

2015 Australasian journal of ultrasound in medicine

49. Capacity building in endometriosis ultrasound: are we there yet? Full Text available with Trip Pro

Capacity building in endometriosis ultrasound: are we there yet? 28191255 2019 01 12 1836-6864 18 4 2015 Nov Australasian journal of ultrasound in medicine Australas J Ultrasound Med Capacity building in endometriosis ultrasound: are we there yet? 129-131 10.1002/j.2205-0140.2015.tb00218.x Menakaya Uche A UA Staff SpecialistObstetrics and Gynecology Calvary Health CareBruce; Director, JUNIC Specialist Imaging and Women's CenterCharnwood Australian Capital TerritoryAustralia. eng Editorial 2015

2015 Australasian journal of ultrasound in medicine

50. Survivin and VEGF as Novel Biomarkers in Diagnosis of Endometriosis Full Text available with Trip Pro

Survivin and VEGF as Novel Biomarkers in Diagnosis of Endometriosis The aim of this study was to investigate the role of peripheral blood markers as additional diagnostic tools to transvaginal ultrasound (TVU) findings in the diagnosis of endometriosis.This study included 40 patients undergoing laparoscopy for suspected endometriosis from January to December 2012. Preoperative levels of serum CA125, CA19-9, CEA and mRNA expression levels for survivin and VEGF were obtained. Real-time PCR (...) was used to determine relative gene expression. A new diagnostic score was obtained by deploying the peripheral blood markers to the TVU findings. Statistical methods used were Chi-square, Fisher's, Student's t-test or the Mann - Whitney test.There was a statistically significant difference in serum CA125, survivin and VEGF levels in patients with endometriosis and those without endometriosis (p<0.001, p=0.025 and p=0.009, respectively). False negative TVU findings were noted in 3/13 patients (23.1

2015 Journal of medical biochemistry

51. Urinary biomarkers for the non-invasive diagnosis of endometriosis. (Abstract)

of the diagnostic accuracy of urinary biomarkers for the diagnosis of pelvic endometriosis compared to surgical diagnosis as a reference standard.2. To assess the diagnostic utility of biomarkers that could differentiate ovarian endometrioma from other ovarian masses.Urinary biomarkers were evaluated as replacement tests for surgical diagnosis and as triage tests to inform decisions to undertake surgery for endometriosis.The searches were not restricted to particular study design, language or publication dates (...) Urinary biomarkers for the non-invasive diagnosis of endometriosis. About 10% of reproductive-aged women suffer from endometriosis which is a costly chronic disease that causes pelvic pain and subfertility. Laparoscopy is the 'gold standard' diagnostic test for endometriosis, but it is expensive and carries surgical risks. Currently, there are no simple non-invasive or minimally-invasive tests available in clinical practice that accurately diagnoses endometriosis.1. To provide summary estimates

2015 Cochrane

52. Robotic single-site excision of ovarian endometrioma Full Text available with Trip Pro

Robotic single-site excision of ovarian endometrioma Conventional single-incision laparoscopic surgery has been successfully employed for treatment of ovarian endometriomas. However, this technique presents surgeons with formidable ergonomic challenges, that make its widespread adoption unlikely. Robotic assistance in single-incision laparoscopic surgery provides adequate instrument triangulation through a single fulcrum, while eliminating ergonomic challenges to the surgeon. The objective (...) of this video is to describe a novel technique of laparoscopic excision and ablation of ovarian endometriomas with single-site robotic assistance. Footage from a single surgical case is shown in our video. The da Vinci Si surgical system with da Vinci Single-Site platform was utilized. A flexible CO2 laser fiber was employed as the main energy tool. To describe a technique of single-incision laparoscopic excision and ablation of endometriomas with robotic assistance. Footage from a single surgical case

2015 Fertility research and practice

53. Initiation of GnRH agonist treatment on 3-5 days postoperatively in endometriosis patients: a randomized controlled trial (Abstract)

Initiation of GnRH agonist treatment on 3-5 days postoperatively in endometriosis patients: a randomized controlled trial Seventy patients with stage III or IV endometriosis were randomly assigned to 2 groups after conservative surgery. Group O (n = 35) received 3 cycles of a 28-day gonadotropin-releasing hormone agonist (GnRH-a) treatment (goserelin, 3.6 mg) starting 3-5 days postoperatively. Group M (n = 35) received the same treatment starting on days 1-5 of menstruation. Groups were further (...) time in group M was much longer that than that in group O (P =.001), and the bleeding rate in group M was significantly higher than that in group O (P =.024, RR = 1.185). In patients with stage III or IV endometriosis, the efficacy of GnRH-a initiated 3-5 days postoperatively was equivalent to that of GnRH-a initiated on days 1-5 of menstruation. Female patients who initiated GnRH-a treatment 3-5 days postoperatively experienced less uterine bleeding during the first cycle of treatment.© 2015

2015 EvidenceUpdates Controlled trial quality: uncertain

54. Hormone Therapy for the Menopause after Endometriosis Surgery – Friend or Foe?

Hormone Therapy for the Menopause after Endometriosis Surgery – Friend or Foe? Hormone Therapy for the Menopause after Endometriosis Surgery - Friend or Foe? - Evidently Cochrane Search and hit Go By March 12, 2015 // In today’s guest blog, Dr Martin Hirsch explains about endometriosis and treatment choices for women who have the menopause induced because of it. It’s Menopause Week here at Evidently Cochrane and as a team including individual bloggers, Cochrane UK, Healthtalk and Menopause UK (...) with their NHS Change Day campaign to ‘Change the Change’, we are summarising the evidence surrounding the menopause to ensure women get the correct facts from reliable evidence. This blog aims to help women who have had the menopause induced through surgery for endometriosis make more informed health decisions at a time of significant change for their mind and body. Endometriosis – what is it and how do I know if I have it? Most women have heard of the menopause. They fear it, but for a select few women

2015 Evidently Cochrane

55. Interventions effective for endometriosis

Interventions effective for endometriosis Interventions effective for endometriosis | Cochrane Primary Care Trusted evidence. Informed decisions. Better health. Enter terms Interventions effective for endometriosis Cochrane Trusted evidence. Informed decisions. Better health. Copyright © 2019 The Cochrane Collaboration | | We use cookies to improve your experience on our site.

2014 Cochrane PEARLS

56. Endometriosis: tackling pain and subfertility

Endometriosis: tackling pain and subfertility Endometriosis: tackling pain and subfertility | Evidently Cochrane sharing the latest Cochrane Reviews Search Main menu Post navigation by If you’re a woman living with endometriosis, the chances are you’ll be coping with chronic pain, and you may be facing fertility problems too. Here we look at a new overview of Cochrane systematic reviews, which brings together the best available evidence on treatments for these two devastating aspects (...) of endometriosis. Credit: Asuncion Bassas- Mujtaba, Wellcome Images It’s , which aims to raise awareness of ‘the invisible disease’, which affects around 176 million girls and women worldwide. It can have a huge impact on the lives of these women. Along with other symptoms, it can cause severe pain and fertility problems. With no available cure, treatment is directed at managing symptoms and trying to limit the effects of the disease. Treatments for pain include medical approaches, such as hormone treatments

2014 Evidently Cochrane

57. Endometriosis: tackling pain and subfertility

Endometriosis: tackling pain and subfertility Endometriosis: tackling pain and subfertility | Evidently Cochrane sharing the latest Cochrane Reviews Search Main menu Post navigation by If you’re a woman living with endometriosis, the chances are you’ll be coping with chronic pain, and you may be facing fertility problems too. Here we look at a new overview of Cochrane systematic reviews, which brings together the best available evidence on treatments for these two devastating aspects (...) of endometriosis. Credit: Asuncion Bassas- Mujtaba, Wellcome Images It’s , which aims to raise awareness of ‘the invisible disease’, which affects around 176 million girls and women worldwide. It can have a huge impact on the lives of these women. Along with other symptoms, it can cause severe pain and fertility problems. With no available cure, treatment is directed at managing symptoms and trying to limit the effects of the disease. Treatments for pain include medical approaches, such as hormone treatments

2014 Evidently Cochrane

58. Endometriosis: tackling pain and subfertility

Endometriosis: tackling pain and subfertility Endometriosis: tackling pain and subfertility - Evidently Cochrane Search and hit Go By March 20, 2014 // Credit: Asuncion Bassas- Mujtaba, Wellcome Images It’s , which aims to raise awareness of ‘the invisible disease’, which affects around 176 million girls and women worldwide. It can have a huge impact on the lives of these women. Along with other symptoms, it can cause severe pain and fertility problems. With no available cure, treatment (...) is directed at managing symptoms and trying to limit the effects of the disease. Treatments for pain include medical approaches, such as hormone treatments, with or without surgery. For women with fertility problems associated with endometriosis, drug treatments, surgery and assisted reproductive technologies (ART) may all be considered. Overviews can really help if you are making decisions about treatments, as they bring together in one place the best evidence we have, summarising systematic reviews

2014 Evidently Cochrane

59. Endometriosis: tackling pain and subfertility

Endometriosis: tackling pain and subfertility Endometriosis: tackling pain and subfertility | Evidently Cochrane sharing the latest Cochrane Reviews Search Main menu Post navigation by If you’re a woman living with endometriosis, the chances are you’ll be coping with chronic pain, and you may be facing fertility problems too. Here we look at a new overview of Cochrane systematic reviews, which brings together the best available evidence on treatments for these two devastating aspects (...) of endometriosis. Credit: Asuncion Bassas- Mujtaba, Wellcome Images It’s , which aims to raise awareness of ‘the invisible disease’, which affects around 176 million girls and women worldwide. It can have a huge impact on the lives of these women. Along with other symptoms, it can cause severe pain and fertility problems. With no available cure, treatment is directed at managing symptoms and trying to limit the effects of the disease. Treatments for pain include medical approaches, such as hormone treatments

2014 Evidently Cochrane

60. Endometriosis: an overview of Cochrane Reviews. Full Text available with Trip Pro

Endometriosis: an overview of Cochrane Reviews. This overview reports on interventions for pain relief and for subfertility in pre-menopausal women with clinically diagnosed endometriosis.The objective of this overview was to summarise the evidence from Cochrane systematic reviews on treatment options for women with pain or subfertility associated with endometriosis.Published Cochrane systematic reviews reporting pain or fertility outcomes in women with clinically diagnosed endometriosis were (...) cases the evidence was of low or very low quality. Anti-TNF-α drugs One review found no evidence of a difference in effectiveness between anti-TNF-α drugs and placebo. However, the evidence was of low quality. Reviews reporting fertility outcomes (8 reviews) Medical interventions Four reviews reported on medical interventions for improving fertility in women with endometriosis. One compared three months of GnRH agonists with a control in women undergoing assisted reproduction and found very low

2014 Cochrane